Common Side Effects Nausea (very common approximately 40% of patients) Flushing Injection site reactions: pain, redness, bruising Headache Vomiting Cough Fatigue Hot flush Skin hyperpigmentation (focal dark patches, especially with repeated use) Seek Immediate Medical Attention For Severe, persistent increase in blood pressure Chest pain, shortness of breath, or irregular heartbeat Signs of severe allergic reaction Persistent or worsening skin darkening Drug Interactions Naltrexone: Bremelanotide may significantly decrease naltrexone exposure, potentially reducing its effectiveness for alcohol/opioid use disorder treatment Orally administered medications: Slowed gastric emptying may affect absorption of other oral drugs Use in Pregnancy Bremelanotide is contraindicated in pregnancy
You might respond: 'I've been tracking calories and exercising five days a week for eight months with minimal weight loss
"That's kind of what sparked our interest" in tracking the calls
Weight trajectories stabilized after 12 months, with only small variations in the distribution of weight outcomes through year two
18 Incidence is rising due to global obesity trends, with even little weight gain increasing the chance of developing IIH or returning after remission
The confusion often arises when patients or providers attempt to apply insulin dosing terminology to semaglutide